WebOpthea Limited is a public Australian biotechnology company . South Yarra, Victoria, Australia 11-50 Post-IPO Debt Public www.opthea.com/ 32,604 Highlights Total Funding Amount $237.9M Contacts 6 Employee Profiles 9 Similar Companies 12 Find More Contacts for Opthea Megan Baldwin CEO, Managing Director Executive Management 1 email found WebTalking Technical 11 Apr 2024 Bell Equipment, Sasol, Opthea Ltd, Master Drilling
OPT Stock News OPTHEA Stock Price Today - Insider
WebApr 14, 2024 · The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated … WebApr 14, 2024 · Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. About Evaxion Biotech A/S . Evaxion Biotech A/S, a clinical-stage biotech … phone chat free trial code
Opthea Completes Patient Dosing in Phase 2a DME Trial
WebMar 15, 2024 · Opthea (ASX:OPT; Nasdaq: OPT) is a biopharmaceutical company developing a novel therapy to address the unmet need in the treatment of highly prevalent and … WebOct 12, 2024 · Our data indicates that Opthea Limited has a market capitalization of AU$446m, and total annual CEO compensation was reported as US$531k for the year to June 2024. We note that's a decrease of... WebApr 12, 2024 · Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. About the company Rewards Trading at 90.9% below our estimate of its fair value Revenue is forecast to grow 85.83% per year Risk Analysis Makes less than USD$1m in revenue ($243K) phone chat free trial los angeles